Expertise in
5
conditions

Yen-lin C. Liu

Taipei Branch, 
Xindian, TPQ, TW 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Taipei Branch, 
Xindian, TPQ, TW 

Overview

Yen-lin Liu practices practicing medicine in Xindian, Taiwan.

Liu is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, and Solitary Fibrous Tumor.

They are actively involved in clinical research, co-authoring 68 peer reviewed articles and participating in 2 clinical trials.

Locations

Taipei Branch, Xindian, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
Enrollment Status: Recruiting
Publish Date: November 19, 2025
Intervention Type: Drug
Study Drug: Oral Repotrectinib (TPX-0005)
Study Phase: Phase 1/Phase 2

68 Total Publications

O-GlcNAcylation expression predicts a favorable prognosis and mitigates malignant phenotypes via MYCN suppression in neuroblastoma.
O-GlcNAcylation expression predicts a favorable prognosis and mitigates malignant phenotypes via MYCN suppression in neuroblastoma.
Journal: Molecular and cellular pediatrics
Published: September 16, 2025

Frequently Asked Questions about Yen-lin C. Liu

Is Yen-lin C. Liu a top-rated expert for Neuroblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Yen-lin C. Liu is classified as an Advanced expert for Neuroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yen-lin C. Liu participate in research or clinical trials?

Yes. Yen-lin C. Liu has published 68 articles and abstracts on conditions like Neuroblastoma. You can view a list of Yen-lin C. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
      View All 33 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile